Top Hedge Fund News, Member Posts, Hedge Fund Daily Indices and more!

3yrs ago Hedge Fund hedgeweek Views: 274

UCITS fund run by Lyxor Chenavari eyes alpha generation as QE creates “unhealthy” market

Submitted By Hugh Leask | 22/06/2020 - 3:34pm -

Continued central bank support amid the Covid-19 pandemic is creating “bubble-style valuations” in markets, according to Chenavari Investment Managers, a London-based credit-focused hedge fund.

The prevailing backdrop is predominantly suited to long/short credit strategies in corporates and financials credit, it said.

In a note to investors, the team managing the Lyxor Chenavari UCITS fund at Chenavari observed how the first half of 2020 saw a “brutal market dip”, which was quickly mitigated by “unprecedented” central bank and government support globally, helping to strengthen markets.

But since then, the disconnect between the souring economic climate and a continued market rally has raised eyebrows.

The current “unhealthy” environment, characterised by bubble-style valuations sustained by central bank support, is leaving markets “in levitation”, the Chenavari UCITS team suggested.

“Never in the history of markets has a crisis of such magnitude been translated into such low risk premiums,” the team said of the credit rally, with investment grade debt yielding 0.65 per cent, whilst junk companies yield 3.7 per cent.

“Obviously, nothing in the ‘real economy’ justifies such euphoria, but one does not fight central banks at their QE game,” the team observed. “The QE-spurred bubble can last for years and years, until the cracks in the real economy and the social disparities it fuels finally push the system over the edge.”

As a result, the Chenavari UCITS team is now turning its focus on alpha generation in its core strategies, trading long and short in corporates and financials.

Currently, corporate trades are tending to be relative value plays, with long and short bets remaining largely idiosyncratic without any specific theme. In financials, meanwhile, the key trade theme has centred around the compression between core and peripheral European banks.

The team has also slashed allocations to convexity in the Lyxor Chenavari UCITS Fund to 5 per cent.

“Naturally, the team continues to keep the capacity to build a very convex profile on the fund, notably via options, which offer better liquidity than tranches,” they wrote.

“At current levels we do not believe it makes sense to chase market beta and as such, the fund’s market exposure will be very limited and tactical.”

The team, whose Lyxor Chenavari UCITS fund has advanced 3.5 per cent year-to-date, and 8.8 per cent over the 12-month period, added that liquidity remains key.

“New market dynamics have created an unhealthy liquidity environment with market makers having a reduced amount of inventory compared to past levels, especially compared to pre-Global Financial Crisis,” they noted.

“In the context of high volatility, we are very wary of being able to move risk very quickly without too much cost, and hence remain focused on the liquidity of the instruments we are trading.”

Tags Coronavirus Markets

Today's Hedge Fund Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.